Baixar PDF

Outros usuários também visualizaram estes artigos

Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy Lorena Lobo de Figueiredo-Pontes; Luiz Fernando Bazzo Catto; Maria de Lourdes Lopes Ferrari Chauffaille; Katia Borgia Barbosa Pagnano; Maria Isabel Ayrosa Madeira; Elenaide Coutinho Nunes; Nelson Hamerschlak; Marcela Cavalcante de Andrade Silva; Thiago Xavier Carneiro; Teresa Cristina Bortolheiro; Tiago Thalles de Freitas; Rosane Isabel Bittencourt; Evandro Maranhão Fagundes; Eduardo Magalhães Rego;
Hematol Transfus Cell Ther. 2024;46:553-69
Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study Yadith Karina Lopez-Garcia; Mayra Valdez-Carrizales; Jorge Adrián Nuñez-Zuno; Elia Apodaca-Chávez; Juan Rangel-Patiño; Roberta Demichelis-Gómez;
Hematol Transfus Cell Ther. 2024;46:366-73
Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia Sergio Rodríguez-Rodríguez; Lorena Guerrero-Torres; María José Díaz-Huízar; Alan Pomerantz; María del Pilar Ortíz-Vilchis; Roberta Demichelis-Gómez;
Hematol Transfus Cell Ther. 2021;43:476-81